BSECompany Update31 Jul 2026 · 31 Jul 2026, 07:37 pm
Investor presentation for the quarter ended June 30, 2026.
Narayana Hrudayalaya Ltd · 539551
✦ AI Summary▲ PositiveResults
Narayana Hrudayalaya Ltd has released an investor presentation for the quarter ended June 30, 2026, highlighting its operational and financial performance. The company reported a consolidated operating revenue of ₹ 26,836 Mn, a change of +78.0% YoY and +3.5% QoQ, and a consolidated EBITDA of ₹ 5,052 Mn at a margin of 18.8%. The company also provided details on its revenue mix, patient footfalls, and ICU occupied bed days.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Investor Presentation
Attachments (1)
📄pdf
Download →
1cc315df-69cb-4e61-8df6-a78f57acb6d5.pdf
View document text
Date of submission: July 31, 2026
To, To,
The Secretary The Secretary
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Exchange Plaza, Bandra Kurla Complex
Phiroze Jeejeebhoy Towers, Mumbai – 400 051
Dalal Street, Mumbai – 400 001
Scrip Code –539551(EQ), 975516 & 976418 Scrip Code- NH
Dear Sir/Madam,
Sub: Investor Presentation for the quarter ended June 30, 2026
With reference to the subject, please find enclosed the Investor Presentation for the quarter ended
June 30, 2026.
Kindly take the above information on record.
Thanking you
Yours faithfully
For Narayana Hrudayalaya Limited
Sridhar S.
Group Company Secretary, Legal & Compliance Officer
Encl.: as above
Earnings Update
Q1 FY27
August 02, 2023
Topic Slide No.
Our Footprint 03
Narayana Health at a Glance 04
Q1 FY27 Highlights 05
Index
Capex 15
Digital Transformation Initiatives 16
Narayana Health ESG Vision – “Health For All” 17
Shareholding Pattern 18
Our Footprint
(as on 1st July 2026)
United Kingdom India
Ophthalmology Centers
Hospitals/ Surgical Centers
Diagnostic Centers
Hospitals/Surgical Centers +
Delhi NCR
Urgent Treatment Centers
Barlborough Jaipur
Rochdale
Guwahati
Lincolnshire
Birmingham
Buckinghamshire Ahmedabad
Jamshedpur
Emersons Devizes Ilford Raipur Kolkata
Green
Gillingham
Shepton Mallet
Southampton Mumbai
Portsmouth
Plymouth
Davanagere
Cayman Islands Shimoga
Bengaluru
Mysore
Health City
Camana Bay
Health City
Cayman Islands
Narayana Health – At a Glance
Total Capacity Beds
6,269
Facility Details No. of Facilities Operational Beds South (India)
Hospitals - 6 | Heart Centres - 2| Clinics -14 |
Diagnostic Centre - 1
India – Hospitals and Heart Centres 20 5,461 Operational Beds - 2,043 (Hospitals) and 132 (HC)
East (India)
India - Clinics and Dialysis Centres (1) 20 0
Hospitals - 7 | Clinics - 4| Dialysis Centre - 1
Operational beds - 2,074
Cayman Islands 2 164
North (India)
Hospitals – 3
United Kingdom 13 330
Operational beds: 838
West (India)
Healthcare Facilities 55 5,955
Hospitals - 2
Operational beds - 374
Total Staff ~20,950
(1)This includes 11 (Eleven) Integrated Care Clinics as on 30th June 2026.
Clinical : ~ 12,900
Non-clinical : ~ 8,050
Key Highlights – Operational & Financial Performance (Q1 FY27)
▪ Narayana Institute of Cardiac Sciences, Bengaluru has performed:
• 2,137 cardiac surgeries in Q1 FY27.
• 19 Pulse Field Ablation procedures in June 2026 for Atrial Fibrillation since launch in India.
▪ Narayana Hospital, Gurugram operationalized -
• CUVIS Ortho Robotic System in Q1 FY27.
• Thulium Laser System (enabling advanced minimally invasive urological procedures).
▪ Wide spectrum of Robotic Surgery performed across our units in Q1 FY27-
Clinical &
• Robotic CBD Exploration
Operational
• Robot-assisted Hiatus & Ventral Hernia Repair + Paraumbilical Lump Excision.
• Robotic Simple Prostatectomy
• Robotic Cytoreductive Surgery
▪ Consolidated operating revenues of ₹ 26,836 Mn in Q1 FY27, a change of +78.0% YoY and +3.5% QoQ
▪ Consolidated EBITDA of ₹ 5,052 Mn in Q1 FY27 at a margin of 18.8%. Consolidated PAT of ₹ 2,073 Mn for
Q1 FY27 at a margin of 7.7%.
Financial ▪ Consolidated Total Borrowings less Cash & Bank Balance and Investments of ₹ 19,671 Mn as on 30th June
Performance 2026, i.e., net debt to equity ratio of 0.42 (Out of which, debt worth US $115 Mn and GBP £150 Mn are
foreign currency denominated).
India Operations – Revenue (Q1 FY27)
₹ Mn
Total* Domestic
13,000
12,552
15,004 12,494 13,196 12,500 C 171
11,316 11,945
12,000
C 162
10,004 11,500
5.6% QoQ 10,961
11,000 C 136 H 12,381
H 11,783
5,004 10,500
H 10,825
10,000
4 9,500
Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27
16.6% YoY H - Hospitals C - Clinics
International YTD Gross Written Premium**
600 438
500 403 405
305 262
10.2% QoQ
100 105
Q1 FY26 Q4 FY26 Q1 FY27
FY26 FY27
58.3% YoY
*Total revenue is excluding ATHMA, Medha and adjusted with Inter Company eliminations 6
** Gross written premium of NH Insurance. The YTD numbers are starting from 1st April of the financial year to the reporting quarters. 6
India Hospital – Revenue Mix (Q1 FY27)
Business Mix(4,7) Specialty-Profile(4,7) Payor-Profile(4,7)
25% 33% 18%
0% 9%
Cardiac Sciences
Medicine and GI sciences
Owned Hospitals(1)
Oncology Domestic Walk-in patients
Operated Hospitals Renal Sciences Insured Patients (5)
Neuro Sciences
Heart Centres Schemes (6)
Orthopaedics
Clinic Business Others International patients
(1) NH owns on freehold basis and operates with the P&L responsibility (5) Insured Patients include Insurance-covered patients, corporate patients (including PSU’s on hospital tariff)
(2) NH operates the hospitals on rental/revenue sharing basis and owns the P&L responsibility (6) Schemes include CGHS, ESIS, other state government schemes
(3) Includes clinics and dialysis centres excl. NHIC (7) Percentages might not add up to 100% due to rounding off
(4) As percentage of operating revenue, excluding NHIC
India Hospitals – Operations Review (Q1 FY27)
ALOS
Average Revenue Per Patient (IP & OP) (1,2)
Days
₹ ‘000 4.5 4.4
164 163
149 4.3 4.3
4.8 5.0 5.1
Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27
Patient Footfalls (IP & OP)(1,3) ICU Occupied Bed Days
‘000 700 67 ‘000
51 70 100 95 96
90 85
300 617 621 80
53 53 57
Q1 FY26 Q4 FY26 Q1 FY27
Q1 FY26 Q4 FY26 Q1 FY27
Hospitals OP Clinics OP IP
(1) OP figures include day-care business. Clinics OP pertains to footfalls related to NHIC.
(2) ARPOB for the period Q1 FY27 was ₹ 19.2 Mn as against ₹ 17.6 Mn in Q1 FY26. 8
(3) Footfalls for IP correspond to Discharges. 8
India Hospitals – Cluster Split (Q1 FY27)
This considers owned/operated hospitals & heart centers in India
Southern Eastern
Bangalore Kolkata Western Northern
Peripheral Peripheral
Regions • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram
• MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • New Delhi
• HSR • Davangere • NMH • Raipur • Jaipur
• Dharwad • NSH
• Kolar
Capacity Beds 1490 800 1453 745 405 882
% of Hospital
Operating 37% 9% 25% 10% 5% 14%
Revenues
YoY Revenue
Growth 20% 14% 14% 18% -1 26 %% 13%
YoY Hospital
10% 7% 5% 10% 44%% 6%
Discharges 2%
OP ARPP(1)
6.0 4.4 4.7 4.5 4.5 5.2
(₹ ‘000) 5.0 3.7 4.5 4.1 4.3 4.6
IP ARPP
254 85 164 141 133 134
(₹ ‘000) 198.3 67.9 121.4 114.7 128.3
(1) OP ARPP includes day care. 9
India Hospitals – Profitability Snapshot (Q1 FY27)
Includes NH India Hospitals
EBITDA and EBITDA Margin (1) Cost Structure
₹ ‘Mn % of Operating Revenues
Chart Title
25.1%
24.8%
2,700 30.0% Rental / Revenue Share (7)
23.9% (2) 23.4% (2) 2% 2% 2%
2,500 25.0% 100%
11% 10% 10%
20.6% 90%
(1) 3,229
2,300 3,106 20.0% 80%
18% (5) 17% 17%
19.2% (2) 70%
2,100 15.0% 60%
50% 24% (3) 23% 23%
1,900 2,309 10.0% 40%
1,700 5.0% 20% 28% 28% 28%
1,500 0.0%
Q1 FY26 Q4 FY26 Q1 FY27
Q1 FY26 Q4 FY26 Q1 FY27
Doctors and Nurses(4) Consumable Expenses(5)
Other Expenses(6) Other Manpower Cost
1) Denotes EBITDA and EBITDA% of India Hospitals 4) Doctors and Nurses = Employee benefits + Professional fees to doctors
2) Denotes EBITDA% of India Hospitals and NHIC Clinics together. 5) Consumable Expenses = Purchase of medical consumables, drugs and surgical equipment
3) EBITDA of NH India for Q1 FY27 stood at ₹ 2,901 Mn (21.9%). net of changes in inventories of medical consumables, drugs and surgical equipment
6) Other Expenses = Overhead expenses + All other expenses
7) Effect of IND AS benefits is not considered
India Insurance – Key Financial Summary ₹ Mn
Financial Parameters Q1 FY27 Q1 FY26
Gross Written Premium 262 17
Reinsurance Premium -10 -1
Net Written Premium 252 16
Change in Reserve -151 -8
Net Earned Premium 101 8
Net Incurred Claims 220 6
Net Commission 2 0
Total Operating Expenses 100 75
Investment Income 20 12
Profit After Tax -201 -60
Key Ratios Q1 FY27 Q1 FY26
Expense Ratio /NWP 41% 454%
Claims Ratio / NEP 219% 72%
Combined Operating Ratio 259% 526%
Solvency Ratio 167% 162%
Cayman Islands (Q1 FY27)
Hospital Revenues Insurance Revenues (CIHL)
US$ Mn US$ Mn
54
[Showing first 8,000 characters — download PDF for full document]